Form 4: Broadwood Partners Increases Stake in STAAR Surgical Co with Recent Stock Purchases

Broadwood Partners, along with related entities and individuals, reports acquiring additional shares of STAAR Surgical Co common stock, increasing their beneficial ownership.

Summary

• On March 4, 2025, Broadwood Partners, L.P. purchased 17,528 shares of STAAR Surgical Co common stock at a weighted average price of $17.0185, with prices ranging from $16.30 to $17.24.
• On the same day, they also purchased 10,425 shares at a weighted average price of $17.6066, with prices ranging from $17.38 to $17.74.
• Following these transactions, Broadwood Partners directly owns 11,981,151 shares.
• Neal C. Bradsher, as President of Broadwood Capital, Inc. (the General Partner of Broadwood Partners), and Neal C. Bradsher individually, may be deemed to indirectly beneficially own these shares.
• Neal C. Bradsher also directly owns 25,900 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The increased stake suggests confidence, but it's a routine transaction.

Positives

• Broadwood Partners' increased investment in STAAR Surgical Co. could be interpreted as a positive signal about the company's prospects.
• The purchases demonstrate confidence from a major shareholder.

Industry Context

Form 4 filings are a routine part of the US equity market and are required by the SEC to provide transparency into the transactions of company insiders and major shareholders.

Key Dates